Key Management
Torsten Goesch
MD, PhD, MBA
Director of Rosetta Capital. Former positions include General Manager, Biogen & Commercial Head, Merck Genetics
Torsten
Founder & Chairman
Ningfeng Fiona Li
MD, PhD, MSc
Specialised in clinical radiation oncology, with extensive scientific experience in tumour research and genetics.
Founder of London Nanjing Life Science (China) Ltd. and Suzhou NG Biomedicine Ltd.
Fiona
CEO & Founder
Andrew Mackie
BSc, LLB, MBA
R&D and Commercial roles at Novartis, Sanofi and Eli Lilly; Chief Business Officer, Ergomed and Head of Life Sciences at IP Group.
Andrew
Director & CBO
Gary Bower
BSc
Specialist in managing clinical trials with 20 + years experience. Founder of GTE Consultancy Ltd supporting small biotechnology companies with clinical and pre-clinical development since 2006.
Gary
COO
Christian Girard
MiM
Founder of Orphan Drugs Industry Advisory and Intelligence (France) a strategic advisory firm with a focus on value creation in the Orphan Drug area.
Christian
Senior Adviser, Regulatory Strategy
William (Bill) Fahl
PhD
Professor of Oncology, Wisconsin Ins. of Medical Research. Inventor of the NG11, NG12 and NG13 technology platform.
Bill
Senior Scientific Adviser